Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

nicholas moore

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Geographic Areas

France

Concepts & Ideas

Procedures

Chemicals & Drugs

Activities & Behaviors

Occupations

Pharmacoepidemiology

Physiology

Drug Interactions

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Moore N
No obvious extra cardiovascular risk associated with low-dose NSAIDs.
Daveluy Amélie; Raignoux Cécile; Miremont-Salamé Ghada; Girodet Pierre-Olivier; Moore Nicholas; Haramburu Françoise; Molimard Mathieu
Drug interactions between inhaled corticosteroids and enzymatic inhibitors.
Dupont Christophe; Foo Jimmy Lee Kok; Garnier Philippe; Moore Nicholas; Mathiex-Fortunet Hèlène; Salazar-Lindo Eduardo;
Oral diosmectite reduces stool output and diarrhea duration in children with acute watery diarrhea.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of nicholas moore (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Moore N
No obvious extra cardiovascular risk associated with low-dose NSAIDs.
Clinical pharmacology and therapeutics 2009;86(6):600-1; author reply 602-4.
2009: Daveluy Amélie; Raignoux Cécile; Miremont-Salamé Ghada; Girodet Pierre-Olivier; Moore Nicholas; Haramburu Françoise; Molimard Mathieu
Drug interactions between inhaled corticosteroids and enzymatic inhibitors.
European journal of clinical pharmacology 2009;65(7):743-5.
2009: Dupont Christophe; Foo Jimmy Lee Kok; Garnier Philippe; Moore Nicholas; Mathiex-Fortunet Hèlène; Salazar-Lindo Eduardo;
Oral diosmectite reduces stool output and diarrhea duration in children with acute watery diarrhea.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2009;7(4):456-62.
2009: Noize Pernelle; Bazin Fabienne; Dufouil Carole; Lechevallier-Michel Nathalie; Ancelin Marie-Laure; Dartigues Jean-François; Tzourio Christophe; Moore Nicholas; Fourrier-Réglat Annie
Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study.
Pharmacoepidemiology and drug safety 2009;18(4):310-9.
2009: Lagnaoui Rajaa; Tournier Marie; Moride Yola; Wolfson Christina; Ducruet Thierry; Bégaud Bernard; Moore Nicholas
The risk of cognitive impairment in older community-dwelling women after benzodiazepine use.
Age and ageing 2009;38(2):226-8.
2009: Rossignol Michel; Abouelfath Abdelilah; Lassalle Regis; Merlière Yvon; Droz Cécile; Bégaud Bernard; Depont Fanny; Moride Yola; Blin Patrick; Moore Nicholas; Fourrier-Réglat Annie
The CADEUS study: burden of nonsteroidal anti-inflammatory drug (NSAID) utilization for musculoskeletal disorders in blue collar workers.
British journal of clinical pharmacology 2009;67(1):118-24.
2009: Moore Nicholas
Homoeopathic product licence. Being useless may be useful.
BMJ (Clinical research ed.) 2009;338():b2334.
2009: Fantino Bruno; Moore Nicholas
The self-reported Montgomery-Asberg Depression Rating Scale is a useful evaluative tool in Major Depressive Disorder.
BMC psychiatry 2009;9():26.
2009: Pariente Antoine; Daveluy Amélie; Laribière-Bénard Anne; Miremont-Salame Ghada; Begaud Bernard; Moore Nicholas
Effect of date of drug marketing on disproportionality measures in pharmacovigilance: the example of suicide with SSRIs using data from the UK MHRA.
Drug safety : an international journal of medical toxicology and drug experience 2009;32(5):441-7.
2008: Pariente Antoine; Helmer Catherine; Merliere Yvon; Moore Nicholas; Fourrier-Réglat Annie; Dartigues Jean-Francois
Prevalence of cholinesterase inhibitors in subjects with dementia in Europe.
Pharmacoepidemiology and drug safety 2008;17(7):655-60.
2008: Grégoire Fleur; Pariente Antoine; Fourrier-Reglat Annie; Haramburu Françoise; Bégaud Bernard; Moore Nicholas
A signal of increased risk of hypoglycaemia with angiotensin receptor blockers caused by confounding.
British journal of clinical pharmacology 2008;66(1):142-5.
2008: Canal-Raffin Mireille; Receveur Mathilde; Martinez Béatrice; Titier Karine; Ohayon Celine; Baldi Isabelle; Molimard Mathieu; Moore Nicholas; Brochard Patrick
Quantification methods of folpet degradation products in plasma with HPLC-UV/DAD: application to an in vivo toxicokinetic study in rats.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2008;865(1-2):106-13.
2008: Fourrier-Réglat Annie; Droz-Perroteau Cécile; Bénichou Jacques; Depont Fanny; Amouretti Michel; Bégaud Bernard; Moride Yola; Blin Patrick; Moore Nicholas;
Impact of prescriber nonresponse on patient representativeness.
Epidemiology (Cambridge, Mass.) 2008;19(2):186-90.
2008: Mittleman M A; Maclure M; Lewis M A; Hall G C; Moore N; Giuliano F; Porst H; Hedelin H; Martin-Morales A; Sobel R E; Reynolds R; Glasser D B
Cardiovascular outcomes among sildenafil users: results of the International Men's Health Study.
International journal of clinical practice 2008;62(3):367-73.
2008: Waller Patrick; Beard Keith; Egberts Toine; Evans Stephen; Hallas Jesper; Hasford Joerg; Laporte Joan-Ramon; Moore Nicholas; Shakir Saad; Sturkenboom Miriam
European commission consultation on pharmacovigilance.
Pharmacoepidemiology and drug safety 2008;17(2):108-9.
2008: Vergne Sébastien; Bennetau-Pelissero Catherine; Lamothe Valérie; Chantre Philippe; Potier Mylène; Asselineau Julien; Perez Paul; Durand Marlène; Moore Nicholas; Sauvant Patrick
Higher bioavailability of isoflavones after a single ingestion of a soya-based supplement than a soya-based food in young healthy males.
The British journal of nutrition 2008;99(2):333-44.
2008: Moore Nicholas D
Paracetamol with ibuprofen: Ibuprofen is a marker of soft tissue infection.
BMJ (Clinical research ed.) 2008;337():a2072.
2008: Pariente Antoine; Dartigues Jean-Francois; Benichou Jacques; Letenneur Luc; Moore Nicholas; Fourrier-Réglat Annie
Benzodiazepines and injurious falls in community dwelling elders.
Drugs & aging 2008;25(1):61-70.
2007: Sagaspe Patricia; Taillard Jacques; Chaumet Guillaume; Moore Nicholas; Bioulac Bernard; Philip Pierre
Aging and nocturnal driving: better with coffee or a nap? A randomized study.
Sleep 2007;30(12):1808-13.
2007: Grenouillet-Delacre Marieke; Verdoux Hélène; Moore Nicholas; Haramburu Françoise; Miremont-Salamé Ghada; Etienne Gabriel; Robinson Philip; Gruson Didier; Hilbert Gilles; Gabinski Claude; Bégaud Bernard; Molimard Mathieu
Life-threatening adverse drug reactions at admission to medical intensive care: a prospective study in a teaching hospital.
Intensive care medicine 2007;33(12):2150-7.
2007: Daveluy Amélie; Vial Thierry; Marty Laurine; Miremont-Salamé Ghada; Moore Nicholas; Haramburu Françoise
[Contact dermatitis caused by acetazolamide under occlusion]
Presse médicale (Paris, France : 1983) 2007;36(12 Pt 1):1756-8.
2007: Depont Fanny; Vargas Frédéric; Dutronc Hervé; Giauque Emmanuelle; Ragnaud Jean-Marie; Galpérine Tatiana; Abouelfath Abdelilah; Valentino Ruddy; Dupon Michel; Hébert Guillaume; Moore Nicholas
Drug-drug interactions with systemic antifungals in clinical practice.
Pharmacoepidemiology and drug safety 2007;16(11):1227-33.
2007: Arimone Yannick; Miremont-Salamé Ghada; Haramburu Françoise; Molimard Mathieu; Moore Nicholas; Fourrier-Réglat Annie; Bégaud Bernard
Inter-expert agreement of seven criteria in causality assessment of adverse drug reactions.
British journal of clinical pharmacology 2007;64(4):482-8.
2007: Malot L; Molimard M; Abouelfatah A; Lignot S; Depont F; Moore N; Fayon M
[Assessment of the handling of inhaler devices: an observational study of children in primary care]
Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie 2007;14(10):1190-5.
2007: Calvet Cyril; Martin Karin; Robert Grégoire; Moore Nicholas; Eftekhari Pirayeh; Farghal Houssam; Molimard Mathieu; Ballanger Philippe
[Treatment of erectile dysfunction by phosphodiesterase-5 inhibitors and nonarteritic anterior ischemic optic neuropathy (NOIAN)]
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 2007;17(5):920-7.
2007: Diatta Thierno; Blazejewski Sylvie; Portier Arnaud; Lignot Séverine; Quesnot Ariane; Moore Nicholas; Fourrier-Réglat Annie
Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey.
Fundamental & clinical pharmacology 2007;21(4):371-8.
2007: Depont F; Fourrier A; Merlière Y; Droz C; Amouretti M; Bégaud B; Bénichou J; Moride Y; Velo G P; Sturkenboom M; Blin P; Moore N;
Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study.
Pharmacoepidemiology and drug safety 2007;16(8):891-900.
2007: Martin-Latry Karin; Pinet Marion; Moore Nicholas
[Increase in thyroid pathologies in France: myth or reality]
Thérapie 2007;62(4):362-4.
2007: Castaing Nadège; Titier Karine; Receveur-Daurel Mathilde; Le-Déodic Maité; Le-bars Delphine; Moore Nicholas; Molimard Mathieu
Quantification of eight new antidepressants and five of their active metabolites in whole blood by high-performance liquid chromatography-tandem mass spectrometry.
Journal of analytical toxicology 2007;31(6):334-41.
2007: Peuskens Joseph; Moore Nicholas; Azorin Jean-Michel; Toumi Mondher; Cochran John
The European sertindole safety and exposure survey: a follow-up study of 8600 patients.
Pharmacoepidemiology and drug safety 2007;16(7):804-11.
2007: Yusup Abdiryim; Upur Halmurat; Tursun Xirali; Berke Bénédicte; Baudrimont Isabelle; Moore Nicholas
[Study on mechanism of abnormal savda munziq flavonoids in induction of apoptosis of Hep2 cells]
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 2007;32(11):1068-71.
2007: Moore Nicholas; Juillet Yves; Bertoye Pierre-Henri;
Integrity of scientific data: transparency of clinical trial data.
Thérapie 2007;62(3):203-9, 211-6.
2007: Titier Karine; Castaing Nadège; Le-Déodic Maité; Le-Bars Delphine; Moore Nicholas; Molimard Mathieu
Quantification of tricyclic antidepressants and monoamine oxidase inhibitors by high-performance liquid chromatography-tandem mass spectrometry in whole blood.
Journal of analytical toxicology 2007;31(4):200-7.
2007: Kelly William N; Arellano Felix M; Barnes Joanne; Bergman Ulf; Edwards I Ralph; Fernandez Alina M; Freedman Stephen B; Goldsmith David I; Huang Kui; Jones Judith K; McLeay Rachel; Moore Nicholas; Stather Rosie H; Trenque Thierry; Troutman William G; van Puijenbroek Eugene; Williams Frank; Wise Robert P;
Guidelines for submitting adverse event reports for publication.
Pharmacoepidemiology and drug safety 2007;16(5):581-7.
2007: Depont F; Fourrier A; Merlière Y; Droz C; Amouretti M; Bégaud B; Bénichou J; Moride Y; Blin P; Moore N;
The CADEUS study: methods and logistics.
Pharmacoepidemiology and drug safety 2007;16(5):571-80.
2007: Picard Stephane; Titier Karine; Etienne Gabriel; Teilhet Emmanuelle; Ducint Dominique; Bernard Marie-Agnes; Lassalle Regis; Marit Gerald; Reiffers Josy; Begaud Bernard; Moore Nicholas; Molimard Mathieu; Mahon Francois-Xavier
Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia.
Blood 2007;109(8):3496-9.
2007: Blazejewski Sylvie; Raymond Nathalie; Lagnaoui Rajaa; Winnock Stéphane; Cochard Jean-François; Petit Laurent; Dosque Jean-Pierre; Fillatreau Christian; Moore Nicholas
How is norepinephrine used in intensive care? A field study.
Thérapie 2007;62(2):143-9.
2007: Sagaspe Patricia; Taillard Jacques; Chaumet Guillaume; Guilleminault Christian; Coste Olivier; Moore Nicholas; Bioulac Bernard; Philip Pierre
Maintenance of wakefulness test as a predictor of driving performance in patients with untreated obstructive sleep apnea.
Sleep 2007;30(3):327-30.
2007: Fantino Bruno; Moore Nicholas; Verdoux Hélène; Auray Jean-Paul
Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder.
International clinical psychopharmacology 2007;22(2):107-15.
2007: Vergne Sébastien; Titier Karine; Bernard Virginie; Asselineau Julien; Durand Marlène; Lamothe Valérie; Potier Mylène; Perez Paul; Demotes-Mainard Jacques; Chantre Philippe; Moore Nicholas; Bennetau-Pelissero Catherine; Sauvant Patrick
Bioavailability and urinary excretion of isoflavones in humans: effects of soy-based supplements formulation and equol production.
Journal of pharmaceutical and biomedical analysis 2007;43(4):1488-94.
2007: Moore Nicholas
Ibuprofen: a journey from prescription to over-the-counter use.
Journal of the Royal Society of Medicine 2007;100 Suppl 48():2-6.
2007: Canal-Raffin Mireille; L'azou Beatrice; Martinez Beatrice; Sellier Elisabeth; Fawaz Fawaz; Robinson Philip; Ohayon-Courtès Celine; Baldi Isabelle; Cambar Jean; Molimard Mathieu; Moore Nicholas; Brochard Patrick
Physicochemical characteristics and bronchial epithelial cell cytotoxicity of Folpan 80 WG(R) and Myco 500(R), two commercial forms of folpet.
Particle and fibre toxicology 2007;4():8.
2007: Pariente Antoine; Gregoire Fleur; Fourrier-Reglat Annie; Haramburu Françoise; Moore Nicholas
Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias.
Drug safety : an international journal of medical toxicology and drug experience 2007;30(10):891-8.
2007: Kelly William N; Arellano Felix M; Barnes Joanne; Bergman Ulf; Edwards Ralph I; Fernandez Alina M; Freedman Stephen B; Goldsmith David I; Huang Kui A; Jones Judith K; McLeay Rachel; Moore Nicholas; Stather Rosie H; Trenque Thierry; Troutman William G; van Puijenbroek Eugene; Williams Frank; Wise Robert P;
Guidelines for submitting adverse event reports for publication.
Drug safety : an international journal of medical toxicology and drug experience 2007;30(5):367-73.
2007: Moore Nicholas
Diclofenac potassium 12.5mg tablets for mild to moderate pain and fever: a review of its pharmacology, clinical efficacy and safety.
Clinical drug investigation 2007;27(3):163-95.
2007: Al Awwadi Najim A; Borrot-Bouttefroy Anne; Umar Anwar; Saucier Cédric; Segur Marie-Claude; Garreau Charles; Canal Mireille; Glories Yves; Moore Nicholas
Effect of Armagnac fractions on human platelet aggregation in vitro and on rat arteriovenous shunt thrombosis in vivo probably not related only to polyphenols.
Thrombosis research 2007;119(4):407-13.
2006: Clyti E; Théophile H; Klisnik J; Daveluy A; Sainte-Marie D; Haramburu F; Moore N; Couppie P
[Paroxetine (Deroxat and spontaneous ecchymosis]
Annales de dermatologie et de vénéréologie 2006;133(12):1011-2.
2006: Korobelnik Jean-François; Moore Nicholas; Blin Patrick; Dharmani Chandrabhan; Berdeaux Gilles
Estimating the yearly number of eyes with treatable neovascular age-related macular degeneration using a direct standardization method and a markov model.
Investigative ophthalmology & visual science 2006;47(10):4270-6.
2006: Castaing Nadege; Titier Karine; Canal-Raffin Mireille; Moore Nicholas; Molimard Mathieu
Postmortem redistribution of two antipsychotic drugs, haloperidol and thioridazine, in the rat.
Journal of analytical toxicology 2006;30(7):419-25.
2006: Daurel-Receveur Mathilde; Titier Karine; Picard Ste Phane; Ducint Dominique; Moore Nicholas; Molimard Mathieu
Fully automated analytical method for mycophenolic acid quantification in human plasma using on-line solid phase extraction and high performance liquid chromatography with diode array detection.
Therapeutic drug monitoring 2006;28(4):505-11.
2006: Lagnaoui Rajaa; Baumevielle Marie; Bégaud Bernard; Pouyanne Pierre; Maurice Gwenaëlle; Depont Fanny; Moore Nicholas
Less use of NSAIDs in long-term than in recent chondroitin sulphate users in osteoarthritis: a pharmacy-based observational study in France.
Thérapie 2006;61(4):341-6.
2006: Lévy Laurie; Martin-Guehl Corinne; Lechevallier-Michel Nathalie; Noize Pernelle; Moore Nicholas; Latry Philippe; Fourrier-Réglat Annie
Use of psychotropic drugs in 0 to 5 years old children in Aquitaine (France): prevalence and associated factors.
Pharmacoepidemiology and drug safety 2006;15(7):504-9.
2006: Philip Pierre; Taillard Jacques; Moore Nicholas; Delord Sandrine; Valtat Cédric; Sagaspe Patricia; Bioulac Bernard
The effects of coffee and napping on nighttime highway driving: a randomized trial.
Annals of internal medicine 2006;144(11):785-91.
2006: Rambelomanana S; Depont F; Forest K; Hébert G; Blazejewski S; Fourrier-Réglat A; Molimard M; Moore N
Antidepressants: general practitioners' opinions and clinical practice.
Acta psychiatrica Scandinavica 2006;113(6):460-7.
2006: Canal-Raffin Mireille; Titier Karine; Déridet Evelyne; Martinez Béatrice; Abouelfath Abdelilah; Miras Alain; Gromb Sophie; Molimard Mathieu; Moore Nicholas
Myocardium distribution of sertindole and its metabolite dehydrosertindole in guinea-pigs.
Biopharmaceutics & drug disposition 2006;27(4):171-9.
2006: Taillard Jacques; Moore Nicholas; Claustrat Bruno; Coste Olivier; Bioulac Bernard; Philip Pierre
Nocturnal sustained attention during sleep deprivation can be predicted by specific periods of subjective daytime alertness in normal young humans.
Journal of sleep research 2006;15(1):41-5.
2006: Arimone Yannick; Bégaud Bernard; Miremont-Salamé Ghada; Fourrier-Réglat Annie; Molimard Mathieu; Moore Nicholas; Haramburu Françoise
A new method for assessing drug causation provided agreement with experts' judgment.
Journal of clinical epidemiology 2006;59(3):308-14.
2006: Joannides Robinson; Moore Nicholas; Iacob Michaela; Compagnon Patricia; Lerebours Guy; Menard Jean-François; Thuillez Christian
Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise.
British journal of clinical pharmacology 2006;61(2):127-37.
2006: Daveluy Amélie; de Bazignan Adélaïde Doussau; Thiessard Frantz; Miremont-Salamé Ghada; Moore Nicholas; Haramburu Françoise;
[Selective serotonin reuptake inhibitors and acne]
Thérapie 2006;61(1):71-2.
2006: de Sèze Marianne; Gallien Philippe; Denys Pierre; Labat Jean-Jacques; Serment Gérard; Grise Philippe; Salle Jean-Yves; Blazejewski Sylvie; Hazane Cécile; Moore Nicholas; Joseph Pierre-Alain
Intravesical glucidic capsaicin versus glucidic solvent in neurogenic detrusor overactivity: a double blind controlled randomized study.
Neurourology and urodynamics 2006;25(7):752-7.
2006: Tohti Ibadet; Tursun Maynur; Umar Anwar; Turdi Subat; Imin Horyat; Moore Nicholas
Aqueous extracts of Ocimum basilicum L. (sweet basil) decrease platelet aggregation induced by ADP and thrombin in vitro and rats arterio--venous shunt thrombosis in vivo.
Thrombosis research 2006;118(6):733-9.
2005: Philip Pierre; Sagaspe Patricia; Taillard Jacques; Valtat Cédric; Moore Nicholas; Akerstedt Torbjorn; Charles André; Bioulac Bernard
Fatigue, sleepiness, and performance in simulated versus real driving conditions.
Sleep 2005;28(12):1511-6.
2005: Laribière Anne; Miremont-Salamé Ghada; Reyre Hadrien; Abouelfath Abdelilah; Liège Ludovic; Moore Nicholas; Haramburu Françoise
Surveillance of adverse effects during a vaccination campaign against meningitis C.
European journal of clinical pharmacology 2005;61(12):907-11.
2005: Titier Karine; Picard Stéphane; Ducint Dominique; Teilhet Emmanuelle; Moore Nicholas; Berthaud Patrice; Mahon François-Xavier; Molimard Mathieu
Quantification of imatinib in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
Therapeutic drug monitoring 2005;27(5):634-40.
2005: Yusup Abdiryim; Upur Halmurat; Baudrimont Isabelle; Umar Anwar; Kader Turghun; Begaud Bernard; Creppy Edmond E; Moore Nicholas
Cytotoxicity of abnormal Savda Munziq aqueous extract in human hepatoma (HepG2) cells.
Fundamental & clinical pharmacology 2005;19(4):465-72.
2005: Moore Nicholas D
Online music model could work for journals.
BMJ (Clinical research ed.) 2005;330(7504):1391.
2005: Sanchez-Ortuno Montserrat; Moore Nicholas; Taillard Jacques; Valtat Cédric; Leger Damien; Bioulac Bernard; Philip Pierre
Sleep duration and caffeine consumption in a French middle-aged working population.
Sleep medicine 2005;6(3):247-51.
2005: Arimone Yannick; Bégaud Bernard; Miremont-Salamé Ghada; Fourrier-Réglat Annie; Moore Nicholas; Molimard Mathieu; Haramburu Françoise
Agreement of expert judgment in causality assessment of adverse drug reactions.
European journal of clinical pharmacology 2005;61(3):169-73.
2005: Moore Nicholas; Verdoux Hélène; Fantino Bruno
Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder.
International clinical psychopharmacology 2005;20(3):131-7.
2005: Philip Pierre; Sagaspe Patricia; Moore Nicholas; Taillard Jacques; Charles André; Guilleminault Christian; Bioulac Bernard
Fatigue, sleep restriction and driving performance.
Accident; analysis and prevention 2005;37(3):473-8.
2005: Moore Nicholas; Thiessard Frantz; Begaud Bernard
The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactions.
Pharmacoepidemiology and drug safety 2005;14(4):285-6.
2005: Martin K; Bentaberry F; Dumoulin C; Longy-Boursier M; Lifermann F; Haramburu F; Dehais J; Schaeverbeke T; Bégaud B; Moore N
Neuropathy associated with leflunomide: a case series.
Annals of the rheumatic diseases 2005;64(4):649-50.
2005: Van Ganse Eric; Jones Judith K; Moore Nicholas; Parc Jean Marie Le; Wall Richard; Schneid Helene
A large simple clinical trial prototype for assessment of OTC drug effects using patient-reported data.
Pharmacoepidemiology and drug safety 2005;14(4):249-55.
2005: Moore Nicholas
Assessing drug safety.
BMJ (Clinical research ed.) 2005;330(7490):539-40.
2005: Daurel-Receveur Mathilde; Miremont-Salamé Ghada; Fourrier Annie; Auriche Pascal; Moore Nicholas; Bégaud Bernard; Haramburu Françoise;
[Antidepressant adverse effects in the elderly: analysis of spontaneous reports in France]
Thérapie 2005;60(1):61-5.
2005: Fourrier-Réglat Annie; de Bailliencourt Ségolène; Molimard Mathieu; Latry Philippe; Moore Nicholas; Peter Claude; Bégaud Bernard
[Celecoxib prescription: data from the "Sécurité Sociale" database of the Aquitaine Region, South-Western, France]
Thérapie 2005;60(1):25-9.
2005: Martin Karin; Moride Yola; Metge Colleen; Moore Nicholas; Bégaud Bernard
Potential impact of oral contraceptive choice on myocardial infarction mortality and deep vein thrombosis.
The journal of family planning and reproductive health care / Faculty of Family Planning & Reproductive Health Care, Royal College of Obstetricians & Gynaecologists 2005;31(1):37-9.
2005: Moore Nicholas D
Placebos in medicine: pain that is relieved by placebo is not therefore unreal.
BMJ (Clinical research ed.) 2005;330(7481):45.
2005: Canal-Raffin Mireille; Déridet Evelyne; Titier Karine; Frakra Eric; Molimard Mathieu; Moore Nicholas
Simplified ultraviolet liquid chromatographic method for determination of sertindole, dehydrosertindole and norsertindole, in human plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2005;814(1):61-7.
2005: Bégaud Bernard; Martin Karin; Abouelfath Abdelilah; Tubert-Bitter Pascale; Moore Nicholas; Moride Yola
An easy to use method to approximate Poisson confidence limits.
European journal of epidemiology 2005;20(3):213-6.
2005: Moride Yola; Ducruet Thierry; Boivin Jean-François; Moore Nicholas; Perreault Sylvie; Zhao Sean
Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.
Arthritis research & therapy 2005;7(2):R333-42.
2005: Titier Karine; Girodet Pierre-Olivier; Verdoux Hélène; Molimard Mathieu; Bégaud Bernard; Haverkamp Wilhelm; Lader Malcolm; Moore Nicholas
Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death.
Drug safety : an international journal of medical toxicology and drug experience 2005;28(1):35-51.
2005: Umar Anwar; Depont Fanny; Jacquet Alain; Lignot Severine; Segur Marie Claude; Boisseau Michel; Bégaud Bernard; Moore Nicholas
Effects of armagnac or vodka on platelet aggregation in healthy volunteers: a randomized controlled clinical trial.
Thrombosis research 2005;115(1-2):31-7.
2004: Moore Nicholas
Transparency and trust: Clear definition of ghost writing would be helpful.
BMJ (Clinical research ed.) 2004;329(7478):1345-6.
2004: Umar Anwar; Boisseau Michel; Yusup Abdiryim; Upur Halmurat; Bégaud Bernard; Moore Nicholas
Interactions between aspirin and COX-2 inhibitors or NSAIDs in a rat thrombosis model.
Fundamental & clinical pharmacology 2004;18(5):559-63.
2004: Moore Nicholas; Diris Hélène; Martin Karin; Viale Raymond; Fourrier Annie; Moride Yola; Bégaud Bernard
NSAID use profiles derived from reimbursement data in France.
Thérapie 2004;59(5):541-6.
2004: Lagnaoui Rajaa; Depont Fanny; Fourrier Annie; Abouelfath Abdelillah; Bégaud Bernard; Verdoux Hélène; Moore Nicholas
Patterns and correlates of benzodiazepine use in the French general population.
European journal of clinical pharmacology 2004;60(7):523-9.
2004: Hasford J; Moore N; Hoye K
Safety and usage pattern of low-dose diclofenac when used as an over-the-counter medication: results of an observational cohort study in a community-based pharmacy setting.
International journal of clinical pharmacology and therapeutics 2004;42(8):415-22.
2004: Yusup Abdiryim; Upur Halmurat; Umar Anwar; Moore Nicholas
Protective effects of Munziq and Mushil of abnormal Savda to mitochondrial oxidative damage.
Fundamental & clinical pharmacology 2004;18(4):471-6.
2004: Titier Karine; Canal Mireille; Déridet Evelyne; Abouelfath Abdelilah; Gromb Sophie; Molimard Mathieu; Moore Nicholas
Determination of myocardium to plasma concentration ratios of five antipsychotic drugs: comparison with their ability to induce arrhythmia and sudden death in clinical practice.
Toxicology and applied pharmacology 2004;199(1):52-60.
2004: Upur Halmurat; Yusup Abdiryim; Umar Anwar; Moore Nicholas
Uighur traditional medicine syndrome of Abnormal Savda in men is associated with oxidative stress, which can be improved by Munziq and Mushil of Abnormal Savda.
Thérapie 2004;59(4):483-4.
2004: Matsika Marcelle-Diane; Tournier Marie; Lagnaoui Rajaa; Pehourcq Fabienne; Molimard Mathieu; Bégaud Bernard; Verdoux Hélène; Moore Nicholas
Comparison of patient questionnaires and plasma assays in intentional drug overdoses.
Basic & clinical pharmacology & toxicology 2004;95(1):31-7.
2004: Philip Pierre; Taillard Jacques; Sagaspe Patricia; Valtat Cédric; Sanchez-Ortuno Montserrat; Moore Nicholas; Charles André; Bioulac Bernard
Age, performance and sleep deprivation.
Journal of sleep research 2004;13(2):105-10.
2004: Martin K; Bégaud B; Verdoux H; Lechevallier N; Latry P; Moore N
Patterns of risperidone prescription: a utilization study in south-west France.
Acta psychiatrica Scandinavica 2004;109(3):202-6.
2004: Mortemousque B; Jacquet A; Richard C; Depont F; Colin J; Moore N
Randomised double masked trial comparing the efficacy and tolerance of 0.05% mequitazine eye drops versus 0.05% levocabastine and placebo in allergic conjunctivitis induced by a conjunctival provocation test with Dermatophagoides pteronyssinus.
The British journal of ophthalmology 2004;88(3):336-40.
2004: Ballantyne Christie M; Riegger Günter; Moore Nicholas; Saia Francesco; Serruys Patrick W J C
Fluvastatin reduces cardiac mortality in patients with coronary heart disease.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2004;18(1):67-75.
2004: Debbarh Ikram; Titier Karine; Deridet Evelyne; Moore Nicholas
Identification and quantitation by high-performance liquid chromatography of mancozeb following derivatization by 1,2-benzenedithiol.
Journal of analytical toxicology 2004;28(1):41-5.
2004: Martin Karin; Bégaud Bernard; Latry Philippe; Miremont-Salamé Ghada; Fourrier Annie; Moore Nicholas
Differences between clinical trials and postmarketing use.
British journal of clinical pharmacology 2004;57(1):86-92.
2004: de Sèze Marianne; Wiart Laurent; de Sèze Mathieu-Panchoa; Soyeur Luc; Dosque Jean-Pierre; Blajezewski Sylvie; Moore Nicholas; Brochet Bruno; Mazaux Jean-Michel; Barat Michel; Joseph Pierre-Alain
Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled study.
The Journal of urology 2004;171(1):251-5.
2003: Girodet Pierre-Olivier; Raherison Chantal; Abouelfath Abdelilah; Lignot Séverine; Depont Fanny; Moore Nicholas; Molimard Mathieu
[Real-life use of inhaler devices for chronic obstructive pulmonary disease in primary care]
Thérapie 2003;58(6):499-504.
2003: Bégaud Bernard; Fourrier Annie; Moore Nicholas; Moride Yola
The delusion of reducing sample size.
European journal of clinical pharmacology 2003;59(8-9):711-2.
2003: Moore Nicholas; Charlesworth Andrew; Van Ganse Eric; LeParc Jean-Marie; Jones Judith K; Wall Richard; Schneid Hélène; Verrière François
Risk factors for adverse events in analgesic drug users: results from the PAIN study.
Pharmacoepidemiology and drug safety 2003;12(7):601-10.
2003: Titier Karine; Castaing Nadège; Scotto-Gomez Emmanuelle; Pehourcq Fabienne; Moore Nicholas; Molimard Mathieu
High-performance liquid chromatographic method with diode array detection for identification and quantification of the eight new antidepressants and five of their active metabolites in plasma after overdose.
Therapeutic drug monitoring 2003;25(5):581-7.
2003: Lagnaoui Rajaa; Moore Nicholas; Moride Yola; Miremont-Salamé Ghada; Bégaud Bernard
Benzodiazepine utilization patterns in Alzheimer's disease patients.
Pharmacoepidemiology and drug safety 2003;12(6):511-5.
2003: Depont F; Rambelomanana S; Le Puil S; Begaud B; Verdoux H; Moore N
Antidepressants: psychiatrists' opinions and clinical practice.
Acta psychiatrica Scandinavica 2003;108(1):24-31.
2003: Moore Nicholas; Hall Gillian; Sturkenboom Miriam; Mann Ron; Lagnaoui Rajaa; Begaud Bernard
Biases affecting the proportional reporting ratio (PPR) in spontaneous reports pharmacovigilance databases: the example of sertindole.
Pharmacoepidemiology and drug safety 2003;12(4):271-81.
2003: Umar Anwar; Guerin Viviane; Renard Martine; Boisseau Michel; Garreau Charles; Begaud Bernard; Molimard Mathieu; Moore Nicholas
Effects of armagnac extracts on human platelet function in vitro and on rat arteriovenous shunt thrombosis in vivo.
Thrombosis research 2003;110(2-3):135-40.
2003: Moore Nicholas; Tubert-Bitter Pascale; Fourrier Anne; Bégaud Bernard
A simple method to estimate sample sizes for safety equivalence studies using inverse sampling.
Journal of clinical epidemiology 2003;56(5):433-5.
2003: Philip Pierre; Sagaspe Patricia; Taillard Jacques; Moore Nicholas; Guilleminault Christian; Sanchez-Ortuno Montserrat; Akerstedt Torbjorn; Bioulac Bernard
Fatigue, sleep restriction, and performance in automobile drivers: a controlled study in a natural environment.
Sleep 2003;26(3):277-80.
2003: Titier K; Bouchet S; Péhourcq F; Moore N; Molimard M
High-performance liquid chromatographic method with diode array detection to identify and quantify atypical antipsychotics and haloperidol in plasma after overdose.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2003;788(1):179-85.
2003: Moore Nicholas
Forty years of ibuprofen use.
International journal of clinical practice. Supplement 2003;(135):28-31.
2003: Molimard Mathiéu; Moore Nicholas
How to design a negative study.
Chest 2003;123(2):655-6; author reply 656.
2003: Moore Nicholas
Place of OTC analgesics and NSAIDs in osteoarthritis.
Inflammopharmacology 2003;11(4):355-62.
2003: Umar Anwar; Boisseau Michel; Segur Marie Claude; Begaud Bernard; Moore Nicholas
Effect of age of Armagnac extract and duration of treatment on antithrombotic effects in a rat thrombosis model.
Thrombosis research 2003;111(3):185-9.
2003: Molimard M; Raherison C; Lignot S; Depont F; Abouelfath A; Moore N
Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care.
Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 2003;16(3):249-54.
2002: Debbarh I; Rambelomanana S; Penouil F; Castaigne F; Poisot D; Moore N
[Human neurotoxicity of ethylene-bis-dithiocarbamates (EBDC)]
Revue neurologique 2002;158(12 Pt 1):1175-80.
2002: Moore N; Le Parc J M; van Ganse E; Wall R; Schneid H; Cairns R
Tolerability of ibuprofen, aspirin and paracetamol for the treatment of cold and flu symptoms and sore throat pain.
International journal of clinical practice 2002;56(10):732-4.
2002: MacDonald Thomas M; Beard Keith; Bruppacher Rudolf; Hasford Joerg; Lewis Michael; Logan Richard F; McNaughton David; Tubert-Bitter Pascale; Van Ganse Eric; Moore Nicholas
The safety of drugs for OTC use: what evidence is required for an NSAID switch?
Pharmacoepidemiology and drug safety 2002;11(7):577-84.
2002: Bégaud Bernard; Martin Karin; Haramburu Françoise; Moore Nicholas
Rates of spontaneous reporting of adverse drug reactions in France.
JAMA : the journal of the American Medical Association 2002;288(13):1588.
2002: Montout Christine; Casadebaig Francoise; Lagnaoui Rajaa; Verdoux Helene; Philippe Alain; Begaud Bernard; Moore Nicholas
Neuroleptics and mortality in schizophrenia: prospective analysis of deaths in a French cohort of schizophrenic patients.
Schizophrenia research 2002;57(2-3):147-56.
2002: Moore Nicholas
War on the roads. People at risk get hit by traffic.
BMJ (Clinical research ed.) 2002;325(7358):277.
2002: Titier Karine; Lagrange Fabrice; Péhourcq Fabienne; Moore Nicholas; Molimard Mathieu
Pharmacokinetic interaction between high-dose methotrexate and oxacillin.
Therapeutic drug monitoring 2002;24(4):570-2.
2002: Titier Karine; Lagrange Fabrice; Péhourcq Fabienne; Edno-Mcheik Leila; Moore Nicholas; Molimard Mathieu
High-performance liquid chromatographic method for the simultaneous determination of the six HIV-protease inhibitors and two non-nucleoside reverse transcriptase inhibitors in human plasma.
Therapeutic drug monitoring 2002;24(3):417-24.
2002: Titier K; Déridet E; Cardone E; Abouelfath A; Moore N
Simplified high-performance liquid chromatographic method for determination of risperidone and 9-hydroxyrisperidone in plasma after overdose.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2002;772(2):373-8.
2002: Rampal P; Moore N; Van Ganse E; Le Parc J M; Wall R; Schneid H; Verrière F
Gastrointestinal tolerability of ibuprofen compared with paracetamol and aspirin at over-the-counter doses.
The Journal of international medical research 2002;30(3):301-8.
2002: Debbarh Ikram; Moore Nicholas
A simple method for the determination of ethylene-thiourea (ETU) in biological samples.
Journal of analytical toxicology 2002;26(4):216-21.
2002: Titier Karine; Déridet Evelyne; Moore Nicholas
In vivo and in vitro myocardial binding of risperidone and 9-hydroxyrisperidone.
Toxicology and applied pharmacology 2002;180(2):145-9.
2002: Titier K; Lagrange F; Péhourcq F; Edno-Mcheik L; Moore N; Molimard M
[Plasmatic dosage of antiretroviral drugs by high performance liquid chromathography ]
Thérapie 2002;57(2):169-74.
2002: Lagnaoui Rajaa; Bégaud Bernard; Moore Nicholas; Chaslerie Anicet; Fourrier Annie; Letenneur Luc; Dartigues Jean François; Moride Yola
Benzodiazepine use and risk of dementia: a nested case-control study.
Journal of clinical epidemiology 2002;55(3):314-8.
2002: Le Parc J M; Van Ganse E; Moore N; Wall R; Schneid H; Verrière F
Comparative tolerability of paracetamol, aspirin and ibuprofen for short-term analgesia in patients with musculoskeletal conditions: results in 4291 patients.
Clinical rheumatology 2002;21(1):28-31.
2001: Lagnaoui R; Moore N; Longy-Boursier M; Baumevieille M; Bégaud B
Benzodiazepine use in patients hospitalized in a department of internal medicine: frequency and clinical correlates.
Pharmacoepidemiology and drug safety 2001;10(6):531-5.
2001: Lagnaoui R; Moore N; Dartigues J F; Fourrier A; Bégaud B
Benzodiazepine use and wine consumption in the French elderly.
British journal of clinical pharmacology 2001;52(4):455-6.
2001: Moore N
Author's reply to criticism of study on benzodiazepines and risk of hip fracture.
BMJ (Clinical research ed.) 2001;323(7315):752-3.
2001: Fourrier A; Letenneur L; Dartigues J F; Moore N; Bégaud B
Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use.
European journal of clinical pharmacology 2001;57(5):419-25.
2001: Moore N; Pierfitte C; Pehourcq F; Lagnaoui R; Bégaud B
Comparison of patient questionnaires, medical records, and plasma assays in assessing exposure to benzodiazepines in elderly subjects.
Clinical pharmacology and therapeutics 2001;69(6):445-50.
2001: Dangoumau J; Fourrier A; Moore N
[Drug evaluation in France: comparison of two approaches]
Thérapie 2001;56(3):307-14.
2001: Moore N
Comment on 'Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use' Tramer et al., Pain 2000;85:169-182.
Pain 2001;91(3):401-2.
2001: Pierfitte C; Macouillard G; Thicoïpe M; Chaslerie A; Pehourcq F; Aïssou M; Martinez B; Lagnaoui R; Fourrier A; Bégaud B; Dangoumau J; Moore N
Benzodiazepines and hip fractures in elderly people: case-control study.
BMJ (Clinical research ed.) 2001;322(7288):704-8.
2001: Moore N
The role of the clinical pharmacologist in the management of adverse drug reactions.
Drug safety : an international journal of medical toxicology and drug experience 2001;24(1):1-7.
2000: Haramburu F; Miremont-Salamé G; Moore N
Good and bad drug prescription in pregnancy.
Lancet 2000;356(9243):1704.
2000: Pierfitte C; Royer R J; Moore N; Bégaud B
The link between sunshine and phototoxicity of sparfloxacin.
British journal of clinical pharmacology 2000;49(6):609-12.
2000: Lagnaoui R; Moore N; Fach J; Longy-Boursier M; Bégaud B
Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability.
European journal of clinical pharmacology 2000;56(2):181-6.
2000: Moore N; Verschuren X; Montout C; Callens J; Kong S X; Bégaud B
Excess costs related to non-steroidal anti-inflammatory drug utilization in general practice.
Thérapie 2000;55(1):133-6.
1999: Joannidès R; Moore N; de la Gueronnière V; Thuillez C
Effect of water on arteries.
Lancet 1999;354(9177):516.
1999: Abenhaim L; Moore N; Bégaud B
The role of pharmacoepidemiology in pharmacovigilance: a conference at the 6th ESOP Meeting, Budapest, 28 September 1998.
Pharmacoepidemiology and drug safety 1999;8 Suppl 1():S1-7.
1999: Pierfitte C; Bégaud B; Lagnaoui R; Moore N D
Is reporting rate a good predictor of risks associated with drugs?
British journal of clinical pharmacology 1999;47(3):329-31.
1999: Bedry R; Deschamps L; Pehourcq F; Moore N; Pillet O; Favarel-Garrigues J C
Non-fatal clozapine (LEPONEX) intoxication with toxicokinetic evaluation.
Veterinary and human toxicology 1999;41(1):20-2.
1998: Moore N; Lecointre D; Noblet C; Mabille M
Frequency and cost of serious adverse drug reactions in a department of general medicine.
British journal of clinical pharmacology 1998;45(3):301-8.
1998: Cailleux N; Marie I; Noblet C; Moore N D; Verdure L; Lévesque H; Courtois H
[Amoxapine-induced pseudopheochromocytoma. Apropos of a case]
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1998;19(2):139-40.
1998: Joannides R; Moore N; Iacob M; Compagnon P; Bacri A M; Thuillez C
Divergent effects of verapamil and amlodipine at rest and during exercise.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1998;16(1):S25-9.
1998: Molimard M; Moore N; Begaud B
Does use or withdrawal of long-acting beta 2-adrenoceptor induce desensitisation?
Lancet 1998;351(9095):66-7.
1997: Joannides R; Bakkali E H; Le Roy F; Rivault O; Godin M; Moore N; Fillastre J P; Thuillez C
Altered flow-dependent vasodilatation of conduit arteries in maintenance haemodialysis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12(12):2623-8.
1997: Moore N; Kreft-Jais C; Haramburu F; Noblet C; Andrejak M; Ollagnier M; Bégaud B
Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database.
British journal of clinical pharmacology 1997;44(5):513-8.
1997: Joannides R; Bakkali el-H; Richard V; Benoist A; Moore N; Thuillez C
Evaluation of the determinants of flow-mediated radial artery vasodilatation in humans.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1997;19(5-6):813-26.
1997: Auriche M; Bertrand P; Blay N; Danan G; Hamel J D; Imbs J L; Lagier G; Micaleff A; Moore N; Ollagnier M; Reveilleau-Richard S; Soubrié C; Weber F
[Good practices of publication of clinical cases of pharmacovigilance: comments, Groupe de Travail sur les Bonnes Pratiques de Publication de Cliniques en Pharmacovigilance: commentary]
Thérapie 1997;52(2):123-7.
1996: Auzou P; Ozsancak C; Hannequin D; Moore N; Augustin P
Clozapine for the treatment of psychosis in Parkinson's disease: a review.
Acta neurologica Scandinavica 1996;94(5):329-36.
1996: Moore N; Vuillemin N; Abiteboul M; Boudignat O; Paliwoda A; Robin J L; Jacobs L D
Large scale safety study of ketoprofen 25 mg (Toprec) in febrile and painful conditions.
Pharmacoepidemiology and drug safety 1996;5(5):295-302.
1996: Moore N; Noblet C; Breemeersch C
[Focus on the safety of ibuprofen at the analgesic-antipyretic dose]
Thérapie 1996;51(4):458-63.
1996: Moore N; Breemeersch C; Noblet C
Renal failure with fluoroquinolones.
Thérapie 1996;51(4):421-3.
1996: Compagnon P; Thiberville L; Moore N; Thuillez C; Lacroix C
Simple high-performance liquid chromatographic method for the quantitation of 5-fluorouracil in human plasma.
Journal of chromatography. B, Biomedical applications 1996;677(2):380-3.
1995: Moore N; Noblet C; Kreft-Jais C; Lagier G; Ollagnier M; Imbs J L
[French pharmacovigilance database system: examples of utilisation]
Thérapie 1995;50(6):557-62.
1995: Lesesve J F; Noblet C; Stamatoullas A; Gueit I; Moore N; Monconduit M
[Adverse hematologic effects of ticlopidine]
Thérapie 1995;50(5):468-70.
1995: Lévesque H; Cailleux N; Moore N; Tilly H; Monconduit M; Courtois H
Autoimmune phenomena associated with cutaneous aseptic necrosis during interferon-alpha treatment for chronic myelogenous leukaemia.
British journal of rheumatology 1995;34(6):582-3.
1995: Moore N; Briffaut C; Noblet C; Normand C A; Thuillez C
Indirect drug-related costs.
Lancet 1995;345(8949):588-9.
1995: Joannides R; Richard V; Moore N; Godin M; Thuillez C
Influence of sympathetic tone on mechanical properties of muscular arteries in humans.
The American journal of physiology 1995;268(2 Pt 2):H794-801.
1995: Lefebvre H; Noblet C; Moore N; Wolf L M
Pseudo-phaeochromocytoma after multiple drug interactions involving the selective monoamine oxidase inhibitor selegiline.
Clinical endocrinology 1995;42(1):95-8; discussion 98-9.
1994: Lesesve J F; Callat M P; Lenormand B; Monconduit M; Noblet C; Moore N; Caron F; Humbert G; Stamatoullas A; Tilly H
Hematological toxicity of ticlopidine.
American journal of hematology 1994;47(2):149-50.
1994: Auzou P; Hannequin D; Landrin I; Cochin J P; Moore N
Worsening of psychotic symptoms by clozapine in Parkinson's disease.
Lancet 1994;344(8927):955.
1994: Tréchot P; Moore N; Bresler L; Castot A; Gay G; Netter P; Royer R
Potassium chloride tablets and small bowel stenoses and perforations: two studies in the French Pharmacovigilance system.
The American journal of gastroenterology 1994;89(8):1268.
1994: Lévesque H; Moore N; Cailleux N; Richard V; Thuillez C; Courtois H
Endothelins. A potential target for pharmacological intervention in diseases of the elderly.
Drugs & aging 1994;4(3):221-37.
1994: Lévesque H; Cailleux N; Vasse D; Legallicier B; Moore N; Borg J Y; Hantute N; Thuillez C; Courtois H
[Evaluation of hospital cost of six days of treatment of deep venous thrombosis. Comparison of subcutaneous nadroparin and intravenous heparin in 40 patients]
Thérapie 1994;49(2):101-5.
1994: Thiberville L; Compagnon P; Moore N; Bastian G; Richard M O; Hellot M F; Vincent C; Kannass M M; Dominique S; Thuillez C
Plasma 5-fluorouracil and alpha-fluoro-beta-alanin accumulation in lung cancer patients treated with continuous infusion of cisplatin and 5-fluorouracil.
Cancer chemotherapy and pharmacology 1994;35(1):64-70.
1994: Moore N; Fresel J; Joannidès R; Compagnon P; Thuillez C
A comparison of the hemodynamic effects of urapidil, prazosin, and clonidine in healthy volunteers.
Blood pressure. Supplement 1994;4():7-12.
1993: Hamelin B A; Moore N; Knupp C A; Ruel M; Vallée F; LeBel M
Cefepime pharmacokinetics in cystic fibrosis.
Pharmacotherapy 1993;13(5):465-70.
1993: Joannides R; Moore N; Richard V; Godin M; Thuillez C
[Mechanical adaptation of muscular arteries to acute increase of blood pressure in man. Contribution of the measurement of arterial wall thickness]
Archives des maladies du coeur et des vaisseaux 1993;86(8):1219-23.
1993: Moore N
Drugs in ancient populations.
Lancet 1993;341(8853):1157.
1993: Moritz F; Petit J; Kaeffer N; Oksenhendler G; Papion H; Hecketsweiler B; Moore N; Winckler C
Metabolic effects of propofol and flunitrazepam given for sedation after aortic surgery.
British journal of anaesthesia 1993;70(4):451-3.
1993: Lévesque H; Cailleux N; Vasse D; Moore N; Legallicier B; Borg J Y; Courtois H
Prevention of venous thromboembolism after major abdominal surgery.
Lancet 1993;341(8848):824-5.
1993: Chassagne P; Mejjad O; Gourmelen O; Moore N; Le Loet X; Deshayes P
Exacerbation of systemic lupus erythematosus during human parvovirus B19 infection.
British journal of rheumatology 1993;32(2):158-9.
1993: Lefebvre H; Richard R; Noblet C; Moore N; Wolf L M
Life-threatening pseudophaeochromocytoma after toloxatone, terbutaline, and phenylephrine.
Lancet 1993;341(8844):555-6.
1993: Doucet J; Fresel J; Thibaut E; Noblet C; Moore N
Changes in the prescription patterns for hypercholesterolaemia in Upper Normandy.
Thérapie 1993;48(1):69-70.
1993: Cailleux N; Noblet C; Moore N; Buquet-Queron V; Lahary A; Godin M
[Furosemide (Lasilix) can be used in patients with G6PD deficiency. Apropos of a case]
Thérapie 1993;48(1):68.
1993: Moore N; Noblet C; Joannidès R; Ollagnier M; Imbs J L; Lagier G
Cough and ACE inhibitors.
Lancet 1993;341(8836):61.
1993: Muir J F; Peiffer G; Richard M O; Benhamou D; Andrejak M; Hary L; Moore N
Lack of effect of magnesium-aluminium hydroxide on the absorption of theophylline given as a pH-dependent sustained release preparation.
European journal of clinical pharmacology 1993;44(1):85-8.
1993: Doucet J; Fresel J; Hue G; Moore N
Protein binding of digitoxin, valproate and phenytoin in sera from diabetics.
European journal of clinical pharmacology 1993;45(6):577-9.
1993: Poldrugo F; Chick J D; Moore N; Walburg J A
Mortality studies in the long-term evaluation of treatment of alcoholics.
Alcohol and alcoholism (Oxford, Oxfordshire). Supplement 1993;2():151-5.
1993: Walburg J A; Vermeulen E C; Chick J D; Moore N; Poldrugo F
Towards a multi-functional diagnostic and evaluation instrument for international comparative research into the quality of the treatment of alcohol problems.
Alcohol and alcoholism (Oxford, Oxfordshire). Supplement 1993;2():133-8.
1992: Lévesque H; Cailleux N; Poutrain J R; Noblet C; Moore N; Courtois H
[Pseudohyperaldosteronism by chronic overdose of "Pulmoll" expectorant lozenges]
Thérapie 1992;47(5):439-40.
1992: Andrejak M; Schmit J L; Tondriaux A; Hary L; Debailleux S; Moore N
[Neurologic side effects of fluoroquinolones. Apropos of 9 cases concerning pefloxacin]
Thérapie 1992;47(5):415-8.
1992: Thirion B; Darmoni S J; Moore N
Costs of medline and CD-ROM searching.
Lancet 1992;340(8814):308.
1992: Fortier-Beaulieu M; Héron F; Noblet C; Cardot F; Manchon N; Moore N; Bourreile J
Misoprostol-associated fever in cirrhotic patient.
Lancet 1992;340(8814):304.
1992: Fortier-Beaulieu M; Noblet C; Cardot F; Thomine E; Moore N; Hemet J; Bourreille J
Possible association of erythema multiforme with acamprosate.
Lancet 1992;339(8799):991.
1992: Lévesque H; Moore N; Thuillez C; Courtois H
[Endothelin. A new class of vasoactive peptides]
Thérapie 1992;47(1):53-6.
1992: Cailleux N; Moore N; Levesque H; Courtois H; Godin M
A low molecular weight heparin decreases plasma aldosterone in patients with primary hyperaldosteronism.
European journal of clinical pharmacology 1992;43(2):185-7.
1991: Le Loët X; Fessard C; Noblet C; Ait Saït L; Moore N
Severe polyarthropathy in an adolescent treated with pefloxacin.
The Journal of rheumatology 1991;18(12):1941-2.
1991: Humbert G; Brumpt I; Montay G; Le Liboux A; Frydman A; Borsa-Lebas F; Moore N
Influence of rifampin on the pharmacokinetics of pefloxacin.
Clinical pharmacology and therapeutics 1991;50(6):682-7.
1991: Lévesque H; Cailleux N; Vuillermet P; Moore N; Thuillez C; Courtois H
[Treatment of erythromelalgia with piroxicam in a patient with acetylsalicylic acid hypersensitivity]
Thérapie 1991;46(6):499-500.
1991: Chassagne P; Humez C; Gourmelen O; Moore N; Le Loet X; Deshayes P
Neurosensory adverse effects after combined phenylbutazone and misoprostol.
British journal of rheumatology 1991;30(5):392.
1991: Doucet J; Moore N; Gancel A; Courtois H; Schrub J C
[Dyschromatopsia and complications of diabetes mellitus. Discriminant analysis]
Presse médicale (Paris, France : 1983) 1991;20(33):1624-5.
1991: Lescut D; Fouin-Fortunet H; Moore N; Petit J; Hecketsweiler B; Lemeland J F; Denis P; Colin R
Liver glutathione and cytochrome P450 activity in experimental infection: study of the relative effects of infectious stress and malnutrition.
Critical care medicine 1991;19(9):1183-7.
1991: Lévesque H; Moore N; Courtois H
Reporting adverse drug reactions by proprietary name.
Lancet 1991;338(8763):393.
1991: Poutrain J R; Lévesque H; Gancel A; Ozenne G; Vuillermet P; Noblet C; Moore N; Courtois H
[Hyperthyroidism under treatment with lithium]
Thérapie 1991;46(4):339.
1991: Moore N; Libert C
Acamprosate, citalopram, and alcoholism.
Lancet 1991;337(8751):1228.
1991: Houdent C; Noblet C; Vandoren C; Levesque H; Morin C; Moore N; Courtois H; Wolf L M
[Hypoglycemia induced by cibenzoline in the elderly]
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1991;12(2):143-5.
1991: Levesque H; Elie-Legrand M C; Noblet C; Gancel A; Moore N; Courtois H
[Megaloblastic anemia secondary to ingestion of metformin]
Thérapie 1991;46(1):89-90.
1991: Levesque H; Cailleux N; Noblet C; Gancel A; Moore N; Courtois H
[Hypoaldosteronism induced by low molecular weight heparins]
Presse médicale (Paris, France : 1983) 1991;20(1):35.
1990: Delangre T; Vernier L; Moore N; Mihout B
[Acute rhabdomyolysis during treatment with ciprofibrate]
Presse médicale (Paris, France : 1983) 1990;19(39):1811-2.
1990: Chassagne P; Levesque H; Moore N
[Methotrexate. Pharmacology applied to the treatment of rheumatoid arthritis]
Thérapie 1990;45(6):499-504.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

nicholas moore

Research Profile (preview)

Geographic Areas

Concepts & Ideas

Procedures

Chemicals & Drugs

Activities & Behaviors

Occupations

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of nicholas moore (preview)

All Publications